ROCKET PHARMACEUTICALS INC
RCKT · NASDAQ
Updated at 2026-10-14 09:06:44
- Today's High
- $2.55
- Today’s Low
- $2.26
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $2.54
- Previous Close
- $2.48
- Volume
- 2.3M
- Market Cap
- $272.24M
- P/E Ratio
- --
- EPS
- $-0.18
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Biotechnology
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- 9 CEDARBROOK DRIVE, CRANBURY, NJ, UNITED STATES, 08512
- Country
- US
- Listing Date
- 2015-02-18
- Fiscal Year End
- December
- Shares Outstanding
- 109.19M
- CIK
- 0001281895
- Website
- www.rocketpharma.com
Rocket Pharmaceuticals, Inc., is a cross-platform biotechnology company focused on developing gene therapies for rare and devastating pediatric diseases. The company is headquartered in Cranbury, New Jersey.
Financial Metrics
Revenue
2026-06-30
$0
2026-03-31
$0
2025-12-31
$0
2025-09-30
$0
Operating Expenses
2026-06-30
$46.92M
2026-03-31
$46.36M
2025-12-31
$43.96M
2025-09-30
$52.24M
Net Income
2026-06-30
$123.21M
2026-03-31
-$47.59M
2025-12-31
-$42.53M
2025-09-30
-$50.33M
Net Profit Margin
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
Earnings Per Share
2026-06-30
$-0.15
2026-03-31
$-0.42
2025-12-31
$-0.38
2025-09-30
$-0.45
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
$134.41M
2026-03-31
-$44.97M
2025-12-31
-$37.01M
2025-09-30
-$46.61M
Effective Tax Rate
2026-06-30
6.53%
2026-03-31
--
2025-12-31
--
2025-09-30
--
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| Operating Expenses | $46.92M | $46.36M | $43.96M | $52.24M |
| Net Income | $123.21M | -$47.59M | -$42.53M | -$50.33M |
| Net Profit Margin | -- | -- | -- | -- |
| Earnings Per Share | $-0.15 | $-0.42 | $-0.38 | $-0.45 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | $134.41M | -$44.97M | -$37.01M | -$46.61M |
| Effective Tax Rate | 6.53% | -- | -- | -- |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.